Breast Cancer Coverage from Every Angle
Editor:
William J. Gradishar, MD, FACP, FASCO
Advertisement
Advertisement

Ongoing CE Activities

A Clinical Case Symposium: New Therapies in Early Breast Cancer
A Clinical Case Symposium: Targeted Therapies in HER2-Positive Breast Cancer
A Primer on Oral Selective Estrogen Receptor Degraders in Metastatic Hormone Receptor-Positive Breast Cancer
Adjuvant Therapy in Hormone Receptor Positive/HER2-Negative Early Breast Cancer: Case Simulations
Breast Cancer Prevention, Screening, Diagnosis, and Treatment
Breast Cancer Risk Assessment and Screening
Data + Perspectives: Clinical Investigators Explore the Current and Future Management of Triple-Negative Breast Cancer
Early Disease Considerations in HER2-Positive Breast Cancer
Inside the Issue — Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer
Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor
Keeping the Outcome in Mind: Applying Best Practices for Managing HR+/HER2- EBC at High Risk of Recurrence
Key Presentations on Breast Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer
Metastatic Disease Considerations in HR-Positive Breast Cancer
MRI in Breast Cancer: Assessment of Response to Neoadjuvant Therapy
Neoadjuvant/Adjuvant Treatment for Breast Cancer With SABCS Updates
Oncology Today with Dr Neil Love: Special Edition — Management of ER-Positive Breast Cancer
Recorded Presentations from the NCCN 2023 Breast Cancer Congress With Updates From The 2022 San Antonio Breast Cancer Symposium
Special Topics in HER2-Positive Breast Cancer
Targeted Approaches to Treating Triple-Negative Breast Cancer: Cases From the Community
The Role of Lifestyle and the Environment in Breast Cancer Risk
Transforming Patient-Centered Care for HR+/HER2- Breast Cancer Patients Through Collaborative Learning: A Toolkit for Clinical Teams
Video Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Breast Cancer
Vision for treating and curing HER2-positive metastatic breast cancer (mBC) in the future
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of ER-Positive Breast Cancer
What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Breast Cancer
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Breast Cancer
Copyright © 2024 National Comprehensive Cancer Network, All Rights Reserved
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.